Literature DB >> 5721943

Pyrazolidines in the treatment of gout.

W C Kuzell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5721943      PMCID: PMC1945463     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  21 in total

1.  Direct determination of uric acid using uricase.

Authors:  T V FEICHTMEIR; H T WRENN
Journal:  Am J Clin Pathol       Date:  1955-07       Impact factor: 2.493

2.  Some observations on 520 gouty patients.

Authors:  W C KUZELL; R W SCHAFFARZICK; W E NAUGLER; P KOETS; E A MANKLE; B BROWN; B CHAMPLIN
Journal:  J Chronic Dis       Date:  1955-12

3.  Liver nucleic acid incorporation of phosphorus32 in rats injected with phenylbutazone.

Authors:  N E DELFEL; A C GRIFFIN
Journal:  Stanford Med Bull       Date:  1953-02

4.  [Butazolidine in therapy of rheumatic diseases; clinical tests with 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine-sodium, a new pyrazol derivative].

Authors:  H K VON RECHENBERG
Journal:  Schweiz Med Wochenschr       Date:  1953-02-14

5.  Treatment of rheumatoid arthritis with butazolidine .

Authors:  J P CURRIE
Journal:  Lancet       Date:  1952-07-05       Impact factor: 79.321

6.  Allopurinol in the treatment of gout.

Authors:  R W Rundles; E N Metz; H R Silberman
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

7.  Studies with allopurinol (HPP) in patients with tophaceous gout.

Authors:  C J Smyth
Journal:  Arthritis Rheum       Date:  1965-10

8.  Potentiation of anticoagulant effect of warfarin by phenylbutazone.

Authors:  P M Aggeler; R A O'Reilly; L Leong; P E Kowitz
Journal:  N Engl J Med       Date:  1967-03-02       Impact factor: 91.245

9.  Phenylbutazone (butazolidin) and butapyrin; a study of clinical effects in arthritis and gout.

Authors:  W C KUZELL; R W SCHAFFARZICK
Journal:  Calif Med       Date:  1952-11

10.  The metabolic fate of phenylbutazone (butazolidin) in man.

Authors:  J J BURNS; R K ROSE; S GOODWIN; J REICHENTHAL; E C HORNING; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1955-04       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.